Literature DB >> 25353356

Distinct patterns of Bcl-2 expression occur in R5- and X4-tropic HIV-1-producing lymphoid tissue cells infected ex vivo.

Michelle K Haas1, David N Levy, Joy M Folkvord, Elizabeth Connick.   

Abstract

Most HIV-1 replication occurs in secondary lymphoid tissues in T cells within B cell follicles. Mechanisms underlying the accumulation of HIV-1-producing cells at these sites are not understood. Antiapoptotic proteins such as Bcl-2 could promote follicular CD4(+) T cell survival, contributing to sustained virus production. Tonsils obtained from subjects without known HIV infection were disaggregated and analyzed for Bcl-2 expression in follicular (CXCR5(+)) and extrafollicular (CXCR5(-)) CD3(+)CD4(+) cells by flow cytometry. Additional tonsil cells were cultured with phytohemagglutinin (PHA) and interleukin-2 (IL-2) for 2 days, infected with either CCR5(R5) or CXCR4-tropic (X4) GFP reporter viruses, and analyzed for Bcl-2 expression. In freshly disaggregated CD3(+)CD4(+) tonsil cells, mean florescence intensity (MFI) for Bcl-2 was higher in CXCR5(+) (median, 292) compared to CXCR5(-) cells (median, 194; p=0.001). Following in vitro stimulation with PHA and IL-2, Bcl-2 MFI was higher in both CXCR5(+) cells (median, 757; p=0.03) and CXCR5(-) cells (median, 884; p=0.002) in uninfected cultures compared to freshly isolated tonsil cells. Bcl-2 MFI was higher in GFP(+)CD3(+)CD8(-) R5-producing cells (median, 554) than in X4-producing cells (median, 393; p=0.02). Bcl-2 MFI was higher in R5-producing CXCR5(+) cells (median, 840) compared to all other subsets including R5-producing CXCR5(-) cells (median, 524; p=0.04), X4-producing CXCR5(+) cells (median, 401; p=0.02), and X4-producing CXCR5(-) cells (median, 332; p=0.008). Bcl-2 expression is elevated in R5 HIV-1-producing CXCR5(+) T cells in vitro, which may contribute to propagation of R5 virus in B cell follicles in vivo.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25353356      PMCID: PMC4348367          DOI: 10.1089/aid.2014.0155

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  50 in total

Review 1.  Control of T cell viability.

Authors:  Philippa Marrack; John Kappler
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

2.  CCR5 expression is reduced in lymph nodes of HIV type 1-infected women, compared with men, but does not mediate sex-based differences in viral loads.

Authors:  Amie L Meditz; Joy M Folkvord; Ngan H Lyle; Kristina Searls; Yolanda S Lie; Eoin P Coakley; Martin McCarter; Samantha Mawhinney; Elizabeth Connick
Journal:  J Infect Dis       Date:  2013-10-31       Impact factor: 5.226

3.  HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo.

Authors:  Amie L Meditz; Michelle K Haas; Joy M Folkvord; Kelsey Melander; Russ Young; Martin McCarter; Samantha Mawhinney; Thomas B Campbell; Yolanda Lie; Eoin Coakley; David N Levy; Elizabeth Connick
Journal:  J Virol       Date:  2011-08-03       Impact factor: 5.103

4.  Simian immunodeficiency virus Nef protein delays the progression of CD4+ T cells through G1/S phase of the cell cycle.

Authors:  Thomas Ndolo; Navdeep K Dhillon; Hau Nguyen; Moraima Guadalupe; Maria Mudryj; Satya Dandekar
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  SDF-1α degrades whereas glycoprotein 120 upregulates Bcl-2 interacting mediator of death extralong isoform: implications for the development of T cell memory.

Authors:  Sergey A Trushin; Alberto A Carena; Gary D Bren; Stacey A Rizza; Xiangyang Dong; Roshini S Abraham; Andrew D Badley
Journal:  J Immunol       Date:  2012-07-16       Impact factor: 5.422

6.  Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell dysfunction.

Authors:  Brent E Palmer; Naomi Blyveis; Andrew P Fontenot; Cara C Wilson
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

7.  Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency.

Authors:  Olaf Kutsch; Etty N Benveniste; George M Shaw; David N Levy
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-κB and inhibition of monocyte chemoattractant protein-1 in urethane-induced lung tumor model.

Authors:  Nam Jin Lee; Dong Young Choi; Ju Kyoung Song; Yu Yeon Jung; Dae Han Kim; Tae Myung Kim; Dae Joong Kim; Sun Mi Kwon; Kyung Bo Kim; Kyung Eun Choi; Dong Cheul Moon; Youngsoo Kim; Sang Bae Han; Jin Tae Hong
Journal:  Carcinogenesis       Date:  2012-08-20       Impact factor: 4.944

9.  CD8+ T cell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaques.

Authors:  Janet M Harouse; Clarisa Buckner; Agegnehu Gettie; Ross Fuller; Rudolf Bohm; James Blanchard; Cecilia Cheng-Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-08       Impact factor: 11.205

10.  Subspecialization of CXCR5+ T cells: B helper activity is focused in a germinal center-localized subset of CXCR5+ T cells.

Authors:  C H Kim; L S Rott; I Clark-Lewis; D J Campbell; L Wu; E C Butcher
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

View more
  11 in total

1.  Follicular Regulatory T Cells Are Highly Permissive to R5-Tropic HIV-1.

Authors:  Shannon M Miller; Brodie Miles; Kejun Guo; Joy Folkvord; Amie L Meditz; Martin D McCarter; David N Levy; Samantha MaWhinney; Mario L Santiago; Elizabeth Connick
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

Review 2.  The Role of the BCL-2 Family of Proteins in HIV-1 Pathogenesis and Persistence.

Authors:  Aswath P Chandrasekar; Nathan W Cummins; Andrew D Badley
Journal:  Clin Microbiol Rev       Date:  2019-10-30       Impact factor: 26.132

3.  Germinal Center T Follicular Helper Cells Are Highly Permissive to HIV-1 and Alter Their Phenotype during Virus Replication.

Authors:  Stephanie L Kohler; Michael N Pham; Joy M Folkvord; Tessa Arends; Shannon M Miller; Brodie Miles; Amie L Meditz; Martin McCarter; David N Levy; Elizabeth Connick
Journal:  J Immunol       Date:  2016-02-12       Impact factor: 5.422

4.  BCL6 represses antiviral resistance in follicular T helper cells.

Authors:  Tohti Amet; Young Min Son; Li Jiang; In Su Cheon; Su Huang; Samir K Gupta; Alexander L Dent; Luis J Montaner; Qigui Yu; Jie Sun
Journal:  J Leukoc Biol       Date:  2017-05-26       Impact factor: 4.962

Review 5.  TFH in HIV Latency and as Sources of Replication-Competent Virus.

Authors:  Brodie Miles; Elizabeth Connick
Journal:  Trends Microbiol       Date:  2016-03-02       Impact factor: 17.079

Review 6.  Tissue reservoirs of HIV.

Authors:  Joseph K Wong; Steven A Yukl
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

7.  Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection.

Authors:  Brodie Miles; Shannon M Miller; Joy M Folkvord; Abigail Kimball; Mastooreh Chamanian; Amie L Meditz; Tessa Arends; Martin D McCarter; David N Levy; Eva G Rakasz; Pamela J Skinner; Elizabeth Connick
Journal:  Nat Commun       Date:  2015-10-20       Impact factor: 14.919

8.  Follicular Regulatory CD8 T Cells Impair the Germinal Center Response in SIV and Ex Vivo HIV Infection.

Authors:  Brodie Miles; Shannon M Miller; Joy M Folkvord; David N Levy; Eva G Rakasz; Pamela J Skinner; Elizabeth Connick
Journal:  PLoS Pathog       Date:  2016-10-07       Impact factor: 6.823

Review 9.  CD4 T Follicular Helper and Regulatory Cell Dynamics and Function in HIV Infection.

Authors:  Brodie Miles; Shannon M Miller; Elizabeth Connick
Journal:  Front Immunol       Date:  2016-12-27       Impact factor: 7.561

Review 10.  Human Immunodeficiency Virus Playing Hide-and-Seek: Understanding the TFH Cell Reservoir and Proposing Strategies to Overcome the Follicle Sanctuary.

Authors:  Yew Ann Leong; Anurag Atnerkar; Di Yu
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.